{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:28:13Z","timestamp":1778862493346,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.drugalcdep.2012.03.005","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T11:02:13Z","timestamp":1333018933000},"page":"313-319","source":"Crossref","is-referenced-by-count":42,"title":["Predictive model accuracy in estimating last \u03949-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC"],"prefix":"10.1016","volume":"125","author":[{"given":"Erin L.","family":"Karschner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Schwope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene W.","family":"Schwilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S1092852900020757","article-title":"Delirium following ingestion of marijuana present in chocolate cookies","volume":"11","author":"Andr\u00e9","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1360-0443.1991.tb01874.x","article-title":"Cannabis psychosis following bhang ingestion","volume":"86","author":"Chaudry","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/JCP.0b013e31822befc1","article-title":"Antagonist-elicited cannabis withdrawal in humans","volume":"31","author":"Gorelick","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/01.WNL.0000152845.09088.28","article-title":"Medical use of cannabis in the Netherlands","volume":"64","author":"Gorter","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.sc.3101982","article-title":"The treatment of spasticity with [Delta]9-tetrahydrocannabinol in persons with spinal cord injury","volume":"45","author":"Hagenbach","year":"2006","journal-title":"Spinal Cord"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002130050848","article-title":"Abstinence symptoms following oral THC administration to humans","volume":"141","author":"Haney","year":"1999","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jat\/16.5.283","article-title":"Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THCCOOH)","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0040","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1373\/clinchem.2005.056838","article-title":"Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations","volume":"51","author":"Huestis","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00007691-200608000-00009","article-title":"Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations","volume":"28","author":"Huestis","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0050","series-title":"The Pharmacology of Marijuana","first-page":"627","article-title":"The 30-day trip \u2013 clinical studies of cannabis tolerance and dependence","author":"Jones","year":"1976"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0055","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/j.1360-0443.2009.02705.x","article-title":"Do Delta 9-Tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?","volume":"104","author":"Karschner","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jat\/33.8.469","article-title":"Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers","volume":"33","author":"Karschner","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chroma.2007.06.069","volume":"1163","author":"Lowe","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2006.05.016","article-title":"A case series of patients using medicinal marihuana for management of chronic pain under the Canadian marijuana medical access regulations","volume":"32","author":"Lynch","year":"2006","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0075","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1373\/clinchem.2008.114405","article-title":"Intra- and inter-subject whole blood\/plasma cannabinoid ratios determined by 2-dimensional, electron impact-gas chromatography, mass spectrometry with cryofocusing","volume":"55","author":"Schwilke","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0080","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1373\/clinchem.2008.122119","article-title":"Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC","volume":"55","author":"Schwilke","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jat\/32.2.160","article-title":"Cannabinoid concentrations in spot serum samples 24\u201348h after discontinuation of cannabis smoking","volume":"32","author":"Skopp","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/TCRM.S5974","article-title":"New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids","volume":"6","author":"Smith","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.drugalcdep.2012.03.005_bib0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jat\/32.7.470","article-title":"Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint","volume":"32","author":"Toennes","year":"2008","journal-title":"J. Anal. Toxicol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T20:23:28Z","timestamp":1543091008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0376871612000798"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.03.005","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}